Global Thrombectomy Devices Market Size, Share | Growth Report 2023-28

IMARC Group, a leading market research company, has recently releases report titled “Thrombectomy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global thrombectomy devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the thrombectomy devices market?

The global thrombectomy devices market size reached US$ 1.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.8 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.

Request for a sample copy of this report: https://www.imarcgroup.com/thrombectomy-devices-market/requestsample

What are thrombectomy devices?

Thrombectomy devices are specialized medical instruments designed to remove blood clots or thrombi from blood vessels, particularly in cases of acute stroke or deep vein thrombosis. These devices play a critical role in restoring blood flow and preventing potential complications. Thrombectomy procedures are minimally invasive and are becoming increasingly important in the field of interventional medicine. As the global healthcare landscape evolves, the demand for Thrombectomy Devices continues to rise due to their effectiveness in improving patient outcomes and reducing the long-term burden of stroke-related disabilities.

What are the growth prospects and trends in the thrombectomy devices industry?

The aging population worldwide is contributing to a higher incidence of vascular diseases and stroke. As a result, there is a growing need for advanced thrombectomy solutions to address these health challenges. In addition, technological advancements in thrombectomy devices, such as the development of stent retrievers and aspiration systems, have improved their efficiency and safety, further fueling market growth. Moreover, healthcare systems worldwide are recognizing the benefits of early intervention with thrombectomy procedures, leading to increased adoption. The COVID-19 pandemic has underscored the importance of efficient healthcare delivery, and thrombectomy devices are playing a crucial role in managing complications related to the virus, such as coagulation disorders. Furthermore, there is a notable trend toward the development of more compact and portable thrombectomy devices, which enhance their accessibility and usability in various clinical settings. This trend aligns with the broader movement towards minimally invasive procedures and outpatient care.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product Type:

• Aspiration Thrombectomy Devices
• Mechanical Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• Others

Breakup by Application:

• Cardiovascular
• Neurovascular
• Peripheral Vascular

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• Argon Medical Devices Inc.
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Medtronic Plc
• Penumbra Inc.
• Spectranetics Corporation (Koninklijke Philips N.V.)
• Stryker Corporation,
• Teleflex Incorporated
• Terumo Corporation.

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3359&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/